These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6322927)

  • 1. An increase in opiate receptor-sites is associated with enhanced cardiovascular depressant, but not respiratory depressant action of morphine.
    Pfeiffer A; Pfeiffer DG; Feuerstein G; Faden AI; Kopin IJ
    Brain Res; 1984 Apr; 296(2):305-11. PubMed ID: 6322927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic naltrexone increases opiate binding in brain and produces supersensitivity to morphine in the locus coeruleus of the rat.
    Bardo MT; Bhatnagar RK; Gebhart GF
    Brain Res; 1983 Dec; 289(1-2):223-34. PubMed ID: 6318895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiorespiratory effects of mu and delta opiate agonists following third or fourth ventricular injections.
    Holaday JW
    Peptides; 1982; 3(6):1023-9. PubMed ID: 6300803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cold-restraint stress reduces [3H]etorphine binding to rat brain membranes: influence of acute and chronic morphine and naloxone.
    Hnatowich MR; Labella FS; Kiernan K; Glavin GB
    Brain Res; 1986 Aug; 380(1):107-13. PubMed ID: 3019462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and respiratory effects of mu-, delta- and kappa-opiate agonists microinjected into the anterior hypothalamic brain area of awake rats.
    Pfeiffer A; Feuerstein G; Kopin IJ; Faden AI
    J Pharmacol Exp Ther; 1983 Jun; 225(3):735-41. PubMed ID: 6306217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naloxazone pretreatment modifies cardiorespiratory, temperature, and behavioral effects of morphine.
    Holaday JW; Pasternak GW; Faden AI
    Neurosci Lett; 1983 Jun; 37(2):199-204. PubMed ID: 6308526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of opioid system in C57 mice after repeated treatment with morphine and naloxone: biochemical and behavioral correlates.
    Brunello N; Volterra A; Di Giulio AM; Cuomo V; Racagni G
    Life Sci; 1984 Apr; 34(17):1669-78. PubMed ID: 6328141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central kappa- and mu-opiate receptors mediate ACTH-release in rats.
    Pfeiffer A; Herz A; Loriaux DL; Pfeiffer DG
    Endocrinology; 1985 Jun; 116(6):2688-90. PubMed ID: 2986960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-opiate and peripheral-opiate cardiovascular effects of morphine in conscious dogs.
    Given MB; Sander GE; Giles TD
    Life Sci; 1986 Apr; 38(14):1299-303. PubMed ID: 3959755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related differences in the effect of chronic administration of naloxone on opiate binding in rat brain.
    Bardo MT; Bhatnagar RK; Gebhart GF
    Neuropharmacology; 1983 Apr; 22(4):453-61. PubMed ID: 6304564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamic regulation of the cardiovascular and respiratory systems: role of specific opiate receptors.
    Faden AI; Feuerstein G
    Br J Pharmacol; 1983 Aug; 79(4):997-1002. PubMed ID: 6317125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opiate receptor supersensitivity produced by chronic naloxone treatment: dissociation of morphine-induced antinociception and conditioned taste aversion.
    Bardo MT; Miller JS; Risner ME
    Pharmacol Biochem Behav; 1984 Oct; 21(4):591-7. PubMed ID: 6095324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opiate-induced enhancement of the effects of naloxone on serum luteinizing hormone levels in the male rat: specificity for Mu agonists.
    Cicero TJ; Owens DP; Schmoeker PF; Meyer ER
    J Pharmacol Exp Ther; 1983 Sep; 226(3):770-5. PubMed ID: 6310081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma catecholamine and cardiovascular responses to morphine and D-ala2-d-leu5-enkephalin in conscious rats.
    Conway EL; Brown MJ; Dollery CT
    Arch Int Pharmacodyn Ther; 1983 Oct; 265(2):244-58. PubMed ID: 6360061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine.
    Randich A; Robertson JD; Willingham T
    Brain Res; 1993 Feb; 603(2):186-200. PubMed ID: 8096421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta versus mu receptors: cardiovascular and respiratory effects of opiate agonists microinjected into nucleus tractus solitarius of cats.
    Hassen AH; Feuerstein G; Pfeiffer A; Faden AI
    Regul Pept; 1982 Nov; 4(6):299-309. PubMed ID: 6294751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential cardiovascular effects mediated by mu and kappa opiate receptors in hindbrain nuclei.
    Hassen AH; Feuerstein G; Faden AI
    Peptides; 1983; 4(5):621-5. PubMed ID: 6318199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine sulfate depression of cardiac function is attenuated by opiate receptor antagonism with naloxone.
    Vargish T; Beamer KC; Daly T; Riggs TR
    Circ Shock; 1987; 23(3):189-95. PubMed ID: 2827907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meptazinol: a novel Mu-1 selective opioid analgesic.
    Spiegel K; Pasternak GW
    J Pharmacol Exp Ther; 1984 Feb; 228(2):414-9. PubMed ID: 6141283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment.
    Tao PL; Law PY; Loh HH
    J Pharmacol Exp Ther; 1987 Mar; 240(3):809-16. PubMed ID: 3031275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.